differentiation 40 Search Results


scd40l  (Elabscience Biotechnology)
93
Elabscience Biotechnology scd40l
Validation of platelet functionality in SAH. (A) Platelet activation/aggregation in SAH histogram shows the percent expression of PAC‐1, P‐selectin (CD62p), and intracellular Ca +2 (secretion) in SAH and HC. (B) Increased expression (relative change) of various mRNA in SAH platelets linked to platelet and complement activation. Protein expression of Gp2b/3a/β‐actin ratio in platelets of patients with SAH. Results expressed as mean ± SEM (* P < 0.05, ** P < 0.01 for SAH versus HC). (C) Patients with SAH showed higher plasma levels of PF‐4 (65.85 ± 0.9457 versus 81.13 ± 6.595 ng/mL, P < 0.02), P‐selectin (6.360 ± 0.1639 versus 10.118 ± 2.1492 ng/mL, P < 0.0001), and soluble cluster of differentiation 40 ligand (1,726 ± 134.4 versus 2,528 ± 1.525.4 pg/mL, P < 0.05). Circulating levels of PF‐4, P‐selectin, and <t>sCD40L</t> correlated with the MELD score in SAH (r > 0.5, P < 0.05). (D) Representative western blot of SNARE complex proteins in platelets isolated from SAH versus HC (n = 5). Results are expressed as mean ± SEM (* P < 0.05, ** P < 0.01, *** P < 0.001 as indicated).
Scd40l, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+40/pmc06939543-58-24-26?v=Elabscience+Biotechnology
Average 93 stars, based on 1 article reviews
scd40l - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
tgf beta 1 recombinant protein  (ProSci Incorporated)
91
ProSci Incorporated tgf beta 1 recombinant protein
Validation of platelet functionality in SAH. (A) Platelet activation/aggregation in SAH histogram shows the percent expression of PAC‐1, P‐selectin (CD62p), and intracellular Ca +2 (secretion) in SAH and HC. (B) Increased expression (relative change) of various mRNA in SAH platelets linked to platelet and complement activation. Protein expression of Gp2b/3a/β‐actin ratio in platelets of patients with SAH. Results expressed as mean ± SEM (* P < 0.05, ** P < 0.01 for SAH versus HC). (C) Patients with SAH showed higher plasma levels of PF‐4 (65.85 ± 0.9457 versus 81.13 ± 6.595 ng/mL, P < 0.02), P‐selectin (6.360 ± 0.1639 versus 10.118 ± 2.1492 ng/mL, P < 0.0001), and soluble cluster of differentiation 40 ligand (1,726 ± 134.4 versus 2,528 ± 1.525.4 pg/mL, P < 0.05). Circulating levels of PF‐4, P‐selectin, and <t>sCD40L</t> correlated with the MELD score in SAH (r > 0.5, P < 0.05). (D) Representative western blot of SNARE complex proteins in platelets isolated from SAH versus HC (n = 5). Results are expressed as mean ± SEM (* P < 0.05, ** P < 0.01, *** P < 0.001 as indicated).
Tgf Beta 1 Recombinant Protein, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+40/pmc09322748-33-0-9?v=ProSci+Incorporated
Average 91 stars, based on 1 article reviews
tgf beta 1 recombinant protein - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier
scd40l  (Cusabio)
93
Cusabio scd40l
Examination of intrinsic cascade pathways. (a) In vitro changes in blood coagulation factor XII activity in human plasma by silica particles of various sizes. The initial rate of reaction of coagulation factor XII was obtained from human plasma, which was obtained from a control sample of human plasma, which did not contain any silica particles, and was measured by fluorescence intensity. Results are expressed as mean ± S.D. ( n = 5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05). RFU: relative fluorescent unit. (b) The level of <t>soluble</t> <t>CD40</t> <t>ligand</t> <t>(sCD40L)</t> and (c) the level of von Willebrand factor (vWF) in mouse plasma. BALB/c mice were intranasally exposed to nSP30, nSP70, mSP300, nSP100 or mSP1000 at a concentration of 500 μg/mouse for 7 days. Twenty-four hours after the final administration, the levels of sCD40L and vWF in the mouse plasma were determined using ELISA. Results are expressed as mean ± S.E. ( n = 4–5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05).
Scd40l, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+40/pmc03751833-163-1-21?v=Cusabio
Average 93 stars, based on 1 article reviews
scd40l - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
scd40 l  (Cusabio)
90
Cusabio scd40 l
Examination of intrinsic cascade pathways. (a) In vitro changes in blood coagulation factor XII activity in human plasma by silica particles of various sizes. The initial rate of reaction of coagulation factor XII was obtained from human plasma, which was obtained from a control sample of human plasma, which did not contain any silica particles, and was measured by fluorescence intensity. Results are expressed as mean ± S.D. ( n = 5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05). RFU: relative fluorescent unit. (b) The level of <t>soluble</t> <t>CD40</t> <t>ligand</t> <t>(sCD40L)</t> and (c) the level of von Willebrand factor (vWF) in mouse plasma. BALB/c mice were intranasally exposed to nSP30, nSP70, mSP300, nSP100 or mSP1000 at a concentration of 500 μg/mouse for 7 days. Twenty-four hours after the final administration, the levels of sCD40L and vWF in the mouse plasma were determined using ELISA. Results are expressed as mean ± S.E. ( n = 4–5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05).
Scd40 L, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+40/pm30530048-95-20-29?v=Cusabio
Average 90 stars, based on 1 article reviews
scd40 l - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
differential pressure transducer dp9-40  (Validyne Engineering)
90
Validyne Engineering differential pressure transducer dp9-40
Examination of intrinsic cascade pathways. (a) In vitro changes in blood coagulation factor XII activity in human plasma by silica particles of various sizes. The initial rate of reaction of coagulation factor XII was obtained from human plasma, which was obtained from a control sample of human plasma, which did not contain any silica particles, and was measured by fluorescence intensity. Results are expressed as mean ± S.D. ( n = 5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05). RFU: relative fluorescent unit. (b) The level of <t>soluble</t> <t>CD40</t> <t>ligand</t> <t>(sCD40L)</t> and (c) the level of von Willebrand factor (vWF) in mouse plasma. BALB/c mice were intranasally exposed to nSP30, nSP70, mSP300, nSP100 or mSP1000 at a concentration of 500 μg/mouse for 7 days. Twenty-four hours after the final administration, the levels of sCD40L and vWF in the mouse plasma were determined using ELISA. Results are expressed as mean ± S.E. ( n = 4–5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05).
Differential Pressure Transducer Dp9 40, supplied by Validyne Engineering, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+40/pmc02752502-79-24-28?v=Validyne+Engineering
Average 90 stars, based on 1 article reviews
differential pressure transducer dp9-40 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
human cluster of differentiation 40 ligand (cd40l)  (Hangzhou Eastbiopharm Co)
90
Hangzhou Eastbiopharm Co human cluster of differentiation 40 ligand (cd40l)
Examination of intrinsic cascade pathways. (a) In vitro changes in blood coagulation factor XII activity in human plasma by silica particles of various sizes. The initial rate of reaction of coagulation factor XII was obtained from human plasma, which was obtained from a control sample of human plasma, which did not contain any silica particles, and was measured by fluorescence intensity. Results are expressed as mean ± S.D. ( n = 5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05). RFU: relative fluorescent unit. (b) The level of <t>soluble</t> <t>CD40</t> <t>ligand</t> <t>(sCD40L)</t> and (c) the level of von Willebrand factor (vWF) in mouse plasma. BALB/c mice were intranasally exposed to nSP30, nSP70, mSP300, nSP100 or mSP1000 at a concentration of 500 μg/mouse for 7 days. Twenty-four hours after the final administration, the levels of sCD40L and vWF in the mouse plasma were determined using ELISA. Results are expressed as mean ± S.E. ( n = 4–5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05).
Human Cluster Of Differentiation 40 Ligand (Cd40l), supplied by Hangzhou Eastbiopharm Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+40/pm27439924-42-6-22?v=Hangzhou+Eastbiopharm+Co
Average 90 stars, based on 1 article reviews
human cluster of differentiation 40 ligand (cd40l) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
differential microelectromechanical pressure sensor 40 pc  (honeywell international)
90
honeywell international differential microelectromechanical pressure sensor 40 pc
Examination of intrinsic cascade pathways. (a) In vitro changes in blood coagulation factor XII activity in human plasma by silica particles of various sizes. The initial rate of reaction of coagulation factor XII was obtained from human plasma, which was obtained from a control sample of human plasma, which did not contain any silica particles, and was measured by fluorescence intensity. Results are expressed as mean ± S.D. ( n = 5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05). RFU: relative fluorescent unit. (b) The level of <t>soluble</t> <t>CD40</t> <t>ligand</t> <t>(sCD40L)</t> and (c) the level of von Willebrand factor (vWF) in mouse plasma. BALB/c mice were intranasally exposed to nSP30, nSP70, mSP300, nSP100 or mSP1000 at a concentration of 500 μg/mouse for 7 days. Twenty-four hours after the final administration, the levels of sCD40L and vWF in the mouse plasma were determined using ELISA. Results are expressed as mean ± S.E. ( n = 4–5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05).
Differential Microelectromechanical Pressure Sensor 40 Pc, supplied by honeywell international, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+40/pmc05455067-139-7-12?v=honeywell+international
Average 90 stars, based on 1 article reviews
differential microelectromechanical pressure sensor 40 pc - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
differential pressure transducers dp-09-40  (Validyne Engineering)
90
Validyne Engineering differential pressure transducers dp-09-40
Examination of intrinsic cascade pathways. (a) In vitro changes in blood coagulation factor XII activity in human plasma by silica particles of various sizes. The initial rate of reaction of coagulation factor XII was obtained from human plasma, which was obtained from a control sample of human plasma, which did not contain any silica particles, and was measured by fluorescence intensity. Results are expressed as mean ± S.D. ( n = 5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05). RFU: relative fluorescent unit. (b) The level of <t>soluble</t> <t>CD40</t> <t>ligand</t> <t>(sCD40L)</t> and (c) the level of von Willebrand factor (vWF) in mouse plasma. BALB/c mice were intranasally exposed to nSP30, nSP70, mSP300, nSP100 or mSP1000 at a concentration of 500 μg/mouse for 7 days. Twenty-four hours after the final administration, the levels of sCD40L and vWF in the mouse plasma were determined using ELISA. Results are expressed as mean ± S.E. ( n = 4–5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05).
Differential Pressure Transducers Dp 09 40, supplied by Validyne Engineering, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+40/pmc03307892-64-6-10?v=Validyne+Engineering
Average 90 stars, based on 1 article reviews
differential pressure transducers dp-09-40 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
differential scanning calorimetry mettler dsc 40 system  (METTLER TOLEDO)
90
METTLER TOLEDO differential scanning calorimetry mettler dsc 40 system
Examination of intrinsic cascade pathways. (a) In vitro changes in blood coagulation factor XII activity in human plasma by silica particles of various sizes. The initial rate of reaction of coagulation factor XII was obtained from human plasma, which was obtained from a control sample of human plasma, which did not contain any silica particles, and was measured by fluorescence intensity. Results are expressed as mean ± S.D. ( n = 5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05). RFU: relative fluorescent unit. (b) The level of <t>soluble</t> <t>CD40</t> <t>ligand</t> <t>(sCD40L)</t> and (c) the level of von Willebrand factor (vWF) in mouse plasma. BALB/c mice were intranasally exposed to nSP30, nSP70, mSP300, nSP100 or mSP1000 at a concentration of 500 μg/mouse for 7 days. Twenty-four hours after the final administration, the levels of sCD40L and vWF in the mouse plasma were determined using ELISA. Results are expressed as mean ± S.E. ( n = 4–5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05).
Differential Scanning Calorimetry Mettler Dsc 40 System, supplied by METTLER TOLEDO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+40/7nkH4eeoxxzXmeS6UGeUnGOCuLet8bl4o1KJWviGkpz8oprynKukzrfKmybPm0oO1OnCagmJCY-105-9-13?v=METTLER+TOLEDO
Average 90 stars, based on 1 article reviews
differential scanning calorimetry mettler dsc 40 system - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
elisa kit mouse soluble cluster of differentiation 40 ligand mbs732869  (MyBiosource Biotechnology)
90
MyBiosource Biotechnology elisa kit mouse soluble cluster of differentiation 40 ligand mbs732869
Examination of intrinsic cascade pathways. (a) In vitro changes in blood coagulation factor XII activity in human plasma by silica particles of various sizes. The initial rate of reaction of coagulation factor XII was obtained from human plasma, which was obtained from a control sample of human plasma, which did not contain any silica particles, and was measured by fluorescence intensity. Results are expressed as mean ± S.D. ( n = 5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05). RFU: relative fluorescent unit. (b) The level of <t>soluble</t> <t>CD40</t> <t>ligand</t> <t>(sCD40L)</t> and (c) the level of von Willebrand factor (vWF) in mouse plasma. BALB/c mice were intranasally exposed to nSP30, nSP70, mSP300, nSP100 or mSP1000 at a concentration of 500 μg/mouse for 7 days. Twenty-four hours after the final administration, the levels of sCD40L and vWF in the mouse plasma were determined using ELISA. Results are expressed as mean ± S.E. ( n = 4–5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05).
Elisa Kit Mouse Soluble Cluster Of Differentiation 40 Ligand Mbs732869, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+40/pm32988867-64-18-19?v=MyBiosource+Biotechnology
Average 90 stars, based on 1 article reviews
elisa kit mouse soluble cluster of differentiation 40 ligand mbs732869 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
differential scanning calorimeter dsc-40  (NETZSCH)
90
NETZSCH differential scanning calorimeter dsc-40
Examination of intrinsic cascade pathways. (a) In vitro changes in blood coagulation factor XII activity in human plasma by silica particles of various sizes. The initial rate of reaction of coagulation factor XII was obtained from human plasma, which was obtained from a control sample of human plasma, which did not contain any silica particles, and was measured by fluorescence intensity. Results are expressed as mean ± S.D. ( n = 5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05). RFU: relative fluorescent unit. (b) The level of <t>soluble</t> <t>CD40</t> <t>ligand</t> <t>(sCD40L)</t> and (c) the level of von Willebrand factor (vWF) in mouse plasma. BALB/c mice were intranasally exposed to nSP30, nSP70, mSP300, nSP100 or mSP1000 at a concentration of 500 μg/mouse for 7 days. Twenty-four hours after the final administration, the levels of sCD40L and vWF in the mouse plasma were determined using ELISA. Results are expressed as mean ± S.E. ( n = 4–5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05).
Differential Scanning Calorimeter Dsc 40, supplied by NETZSCH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+40/10__5897_slash_ajpp2013__3463-88-21-25?v=NETZSCH
Average 90 stars, based on 1 article reviews
differential scanning calorimeter dsc-40 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
mouse scd40l platinum elisa  (Cusabio)
85
Cusabio mouse scd40l platinum elisa
Examination of intrinsic cascade pathways. (a) In vitro changes in blood coagulation factor XII activity in human plasma by silica particles of various sizes. The initial rate of reaction of coagulation factor XII was obtained from human plasma, which was obtained from a control sample of human plasma, which did not contain any silica particles, and was measured by fluorescence intensity. Results are expressed as mean ± S.D. ( n = 5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05). RFU: relative fluorescent unit. (b) The level of <t>soluble</t> <t>CD40</t> <t>ligand</t> <t>(sCD40L)</t> and (c) the level of von Willebrand factor (vWF) in mouse plasma. BALB/c mice were intranasally exposed to nSP30, nSP70, mSP300, nSP100 or mSP1000 at a concentration of 500 μg/mouse for 7 days. Twenty-four hours after the final administration, the levels of sCD40L and vWF in the mouse plasma were determined using ELISA. Results are expressed as mean ± S.E. ( n = 4–5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05).
Mouse Scd40l Platinum Elisa, supplied by Cusabio, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+40/pm24731558-45-7-13?v=Cusabio
Average 85 stars, based on 1 article reviews
mouse scd40l platinum elisa - by Bioz Stars, 2026-08
85/100 stars
  Buy from Supplier

Image Search Results


Validation of platelet functionality in SAH. (A) Platelet activation/aggregation in SAH histogram shows the percent expression of PAC‐1, P‐selectin (CD62p), and intracellular Ca +2 (secretion) in SAH and HC. (B) Increased expression (relative change) of various mRNA in SAH platelets linked to platelet and complement activation. Protein expression of Gp2b/3a/β‐actin ratio in platelets of patients with SAH. Results expressed as mean ± SEM (* P < 0.05, ** P < 0.01 for SAH versus HC). (C) Patients with SAH showed higher plasma levels of PF‐4 (65.85 ± 0.9457 versus 81.13 ± 6.595 ng/mL, P < 0.02), P‐selectin (6.360 ± 0.1639 versus 10.118 ± 2.1492 ng/mL, P < 0.0001), and soluble cluster of differentiation 40 ligand (1,726 ± 134.4 versus 2,528 ± 1.525.4 pg/mL, P < 0.05). Circulating levels of PF‐4, P‐selectin, and sCD40L correlated with the MELD score in SAH (r > 0.5, P < 0.05). (D) Representative western blot of SNARE complex proteins in platelets isolated from SAH versus HC (n = 5). Results are expressed as mean ± SEM (* P < 0.05, ** P < 0.01, *** P < 0.001 as indicated).

Journal: Hepatology Communications

Article Title: Hyperoxidized Albumin Modulates Platelets and Promotes Inflammation Through CD36 Receptor in Severe Alcoholic Hepatitis

doi: 10.1002/hep4.1440

Figure Lengend Snippet: Validation of platelet functionality in SAH. (A) Platelet activation/aggregation in SAH histogram shows the percent expression of PAC‐1, P‐selectin (CD62p), and intracellular Ca +2 (secretion) in SAH and HC. (B) Increased expression (relative change) of various mRNA in SAH platelets linked to platelet and complement activation. Protein expression of Gp2b/3a/β‐actin ratio in platelets of patients with SAH. Results expressed as mean ± SEM (* P < 0.05, ** P < 0.01 for SAH versus HC). (C) Patients with SAH showed higher plasma levels of PF‐4 (65.85 ± 0.9457 versus 81.13 ± 6.595 ng/mL, P < 0.02), P‐selectin (6.360 ± 0.1639 versus 10.118 ± 2.1492 ng/mL, P < 0.0001), and soluble cluster of differentiation 40 ligand (1,726 ± 134.4 versus 2,528 ± 1.525.4 pg/mL, P < 0.05). Circulating levels of PF‐4, P‐selectin, and sCD40L correlated with the MELD score in SAH (r > 0.5, P < 0.05). (D) Representative western blot of SNARE complex proteins in platelets isolated from SAH versus HC (n = 5). Results are expressed as mean ± SEM (* P < 0.05, ** P < 0.01, *** P < 0.001 as indicated).

Article Snippet: Plasma‐citrated blood samples were centrifuged for 15 minutes at 3,000 g , and levels of PF‐4 (E‐EL‐H2216; Elabscience, Houston, TX), P‐selectin (E‐EL‐H0917; Elabscience), and sCD40L (E‐EL‐H0035; Elabscience) were measured.

Techniques: Biomarker Discovery, Activation Assay, Expressing, Clinical Proteomics, Western Blot, Isolation

Examination of intrinsic cascade pathways. (a) In vitro changes in blood coagulation factor XII activity in human plasma by silica particles of various sizes. The initial rate of reaction of coagulation factor XII was obtained from human plasma, which was obtained from a control sample of human plasma, which did not contain any silica particles, and was measured by fluorescence intensity. Results are expressed as mean ± S.D. ( n = 5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05). RFU: relative fluorescent unit. (b) The level of soluble CD40 ligand (sCD40L) and (c) the level of von Willebrand factor (vWF) in mouse plasma. BALB/c mice were intranasally exposed to nSP30, nSP70, mSP300, nSP100 or mSP1000 at a concentration of 500 μg/mouse for 7 days. Twenty-four hours after the final administration, the levels of sCD40L and vWF in the mouse plasma were determined using ELISA. Results are expressed as mean ± S.E. ( n = 4–5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05).

Journal: Particle and Fibre Toxicology

Article Title: Intranasal exposure to amorphous nanosilica particles could activate intrinsic coagulation cascade and platelets in mice

doi: 10.1186/1743-8977-10-41

Figure Lengend Snippet: Examination of intrinsic cascade pathways. (a) In vitro changes in blood coagulation factor XII activity in human plasma by silica particles of various sizes. The initial rate of reaction of coagulation factor XII was obtained from human plasma, which was obtained from a control sample of human plasma, which did not contain any silica particles, and was measured by fluorescence intensity. Results are expressed as mean ± S.D. ( n = 5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05). RFU: relative fluorescent unit. (b) The level of soluble CD40 ligand (sCD40L) and (c) the level of von Willebrand factor (vWF) in mouse plasma. BALB/c mice were intranasally exposed to nSP30, nSP70, mSP300, nSP100 or mSP1000 at a concentration of 500 μg/mouse for 7 days. Twenty-four hours after the final administration, the levels of sCD40L and vWF in the mouse plasma were determined using ELISA. Results are expressed as mean ± S.E. ( n = 4–5). ** and * represent significant differences from the control (** p < 0.01, * p < 0.05).

Article Snippet: TF, sCD40L, and vWF levels in plasma were determined using enzyme-linked immunosorbent assay (ELISA) kits (TF: Mouse Tissue Factor ELISA kit (Cusabio, Newark, DE, USA); sCD40L: Mouse sCD40L ELISA (eBioscience, San Diego, CA, USA); vWF: Mouse von Willebrand Factor ELISA kit (Cusabio, Newark, DE, USA)).

Techniques: In Vitro, Coagulation, Activity Assay, Clinical Proteomics, Control, Fluorescence, Concentration Assay, Enzyme-linked Immunosorbent Assay